Opinion|Videos|July 1, 2024
Future Directions for Imaging and Biopsy in Prostate Cancer
The panel offers key takeaways on the evolving landscape for imaging and biopsy in prostate cancer, highlighting the role for fusion-guided biopsy in the diagnosis and management of prostate cancer.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What clinical challenges and unmet needsremain regarding biopsy options in the diagnosis and management of patients with prostate cancer?
- What’s next? Are there any emerging technologies or data that you’re excited about in this area? Is there a role for fusion-guided biopsy with PSMA PET imaging in prostate cancer?
- Please share any closing thoughts or key takeaways regarding the use of fusion-guidedbiopsy in the diagnosis and management of prostate cancer?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Annual ACS NCDB report details national trends in prostate cancer care
2
Treatment Selection in Advanced Prostate Cancer
3
FDA provides guidance on development pathway for testosterone therapy for women
4
Strategic Use of ADT in mCSPC From Selection to Escalation
5